Citi Knock-Out PBB/ DE000KB24XD8 /
20/06/2024 14:08:10 | Var.0.000 | Denaro20/06/2024 | Lettera20/06/2024 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.320EUR | 0.00% | 0.320 Quantità in denaro: 25,000 |
- Quantità in lettera: - |
DT.PFANDBRIEFBK AG | 2.1165 - | 31/12/2078 | Call |
GlobeNewswire
14:55
TEN, Ltd. Reports Profits for the First Quarter 2024 and Sets Date for First Common Share Semi-Annua...
GlobeNewswire
14:55
Enterprise tech purchases are stalling in a Bermuda Triangle of complexity, as buyers rely on video,...
GlobeNewswire
14:45
ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation Syste...
GlobeNewswire
14:45
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire
14:45
BAE Systems and GlobalFoundries Collaborate to Strengthen Supply of Essential Semiconductors for Nat...
GlobeNewswire
14:39
Telos Corporation to Participate in Northland Capital Markets Virtual Growth Conference on June 25, ...
GlobeNewswire
14:31
Foremost Lithium Announces Application to List on Upstream – A Next Generation Exchange
GlobeNewswire
14:30
Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conferen...
GlobeNewswire
14:30
iPower Enhances Supply Chain Operations with New Manufacturing Partner in Vietnam
GlobeNewswire
14:30
Zapp EV Reports Financial Results for the First Half of Fiscal Year 2024 and Raises Business Outlook
GlobeNewswire
14:30
Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the ...
GlobeNewswire
14:30
Banzai Unveils Significant Stability and Performance Enhancements for Demio, Boosting User Experienc...
GlobeNewswire
14:30
Golden Triangle Ventures Provides Full Update on Its Flagship Destino Ranch Project
GlobeNewswire
14:30
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
GlobeNewswire
14:30
Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locati...
GlobeNewswire
14:30
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel (cem...